Financials

  • Market Capitalization 7.44 M
  • Employee 8
  • Founded 2017
  • CEO N/A
  • Website www.cnspharma.com
  • Headquarter Nevada, United States
  • FIGI BBG00PM24T16
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.15
Rapporto prezzo/fatturato
-909.61

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4874
ELOX
Eloxx Pharmaceuticals, Inc.
11.35 USD-3.90%-5.42%-23.57%+13.50%7.81 M USD
4882
ASBP
Aspire Biopharma Holdings, Inc. - Common Stock
5.97 USD-0.67%+1.02%+18.45%+282.69%7.73 M USD
4894
BOLT
Bolt Biotherapeutics, Inc. - Common Stock
3.78 USD0.00%-8.25%-20.25%-36.47%7.26 M USD
4898
IMRN
Immuron Limited - American Depositary Shares
1.22 USD-0.81%+5.17%+5.17%-32.97%7.14 M USD

Notizie